S Gütz

Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer

G. Goeckenjan, H. Sitter, Michael Thomas et al. · Pneumologie · 2010 · 150 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Epidermal Growth Factor Receptor-Related Tumor Markers and Clinical Outcomes with Erlotinib in Non-small Cell Lung Cancer: An Analysis of Patients from German Centers in the TRUST Study

Claus-Peter Schneider, David F. Heigener, Kathrin Schott-von-Römer et al. · Journal of Thoracic Oncology · 2008 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial

Petros Christopoulos, Walburga Engel-Riedel, Christian Grohé et al. · Annals of Oncology · 2017 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program

Nikolaj Frost, Petros Christopoulos, Diego Kauffmann‐Guerrero et al. · Therapeutic Advances in Medical Oncology · 2021 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib

Martin Schüler, Jürgen R. Fischer, Christian Grohé et al. · The Oncologist · 2014 · 28 citations · Full text

Medicine, Oncology, Pharmacology +13